Phase 4Not yet recruitingINTERVENTIONAL
Metabolic Surgery for Atrial Fibrillation Elimination
ClinicalTrials.gov · NCT07027969 · Registry updated: 2026-04-17
- Condition / research focus
- Atrial Fibrillation; Obesity and Obesity-related Medical Conditions
- Sponsor
- Ali Aminian
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2026-11-01. Completion: 2030-03-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Roux-en-Y Gastric Bypass or Sleeve Gastrectomy (procedure) — also listed as: Roux-en-Y Gastric Bypass (RYGB), Sleeve Gastrectomy (SG), Bariatric Surgery
- Anti-Obesity Medication (AOM) treatment (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- The Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported